← Evidence map

ArticlePharmaceuticals (Basel, Switzerland)2026

Multitarget Strategy for Treatment of Pulmonary Arterial Hypertension: Combination of Mesenchymal Cells with Novel PDE-4 Inhibitor.

Bruno Eduardo Dematté et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Multitarget Strategy for Treatment of Pulmonary Arterial Hypertension: Combination of Mesenchymal Cells with Novel PDE-4 Inhibitor. | OpenQuestion